UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 27, 2005
__________
SIGA Technologies, Inc.
-----------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 0-23047 13-3864870
-------- ------- ----------
(State or other Jurisdiction of (Commission File (I.R.S. Employer
Incorporation or Organization) Number) Identification Number)
420 Lexington Avenue, Suite 408, New York, New York 10170
--------------------------------------------------- -----
(Address of Principal Executive Offices) (Zip Code)
(212) 672-9100
--------------
(Registrant's telephone number, including area code)
ITEM 1.01. Entry Into A Material Definitive Agreement
------------------------------------------
On April 27, 2005, SIGA Technologies, Inc., a Delaware corporation
("SIGA"), entered into a Service Agreement, dated as of April 27, 2005, between
SIGA and TransTech Pharma, Inc., a Delaware corporation ("TransTech"), a copy of
which is filed herewith as Exhibit 10.1. The Service Agreement provides that
TransTech shall provide assistance with the pre-IND toxicology and safety
pharmacology and chemical manufacturing and control studies required for SIGA's
IND application for a proprietary compound. TransTech is a significant
stockholder of SIGA, and the President and Chief Executive Officer of TransTech
is a member of SIGA's board of directors. In addition, SIGA and TransTech are
parties to a drug discovery collaboration agreement.
On April 29, 2005, SIGA entered into a Master Security Agreement, dated as
of April 29, 2005, between General Electric Capital Corporation ("GE") and SIGA,
a copy of which is filed herewith as Exhibit 10.2. Under the Master Security
Agreement, SIGA will grant to GE a security interest in and against certain
property to secure equipment financed through GE. As of the date hereof, no
equipment has been so financed.
ITEM 9.01. Financial Statements and Exhibits
---------------------------------
(c) Exhibits
Exhibit No. Description
----------- -----------
10.1 Service Agreement, dated as of April 27, 2005, between SIGA
Technologies, Inc. and TransTech Pharma, Inc.
10.2 Master Security Agreement, dated as of April 29, 2005,
between General Electric Capital Corporation and SIGA
Technologies, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SIGA TECHNOLOGIES, INC.
By: /s/ Thomas N. Konatich
-----------------------------
Thomas N. Konatich
Chief Financial Officer
Date: May 3, 2005
EXHIBIT INDEX
-------------
Exhibit No. Description
----------- -----------
10.1 Service Agreement, dated as of April 27, 2005, between SIGA
Technologies, Inc. and TransTech Pharma, Inc.
10.2 Master Security Agreement, dated as of April 29, 2005,
between General Electric Capital Corporation and SIGA
Technologies, Inc.